Jay Marshall Feingold
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 14
- CAR-T cell therapy research 6
- HER2/EGFR in Cancer Research 6
-
- Lymphoma Diagnosis and Treatment 7
- Co-authors
- Anna Berkenblit (6 shared papers)Andrew Louis Strahs (5 shared papers)Karin Havenith (8 shared papers)Mehdi Hamadani (12 shared papers)Paolo Fabrizio Caimi (11 shared papers)John A. Radford (10 shared papers)David Ungar (8 shared papers)Melhem Solh (9 shared papers)
- Journals
- Blood (6 papers)Hematological Oncology (5 papers)Bone Marrow Transplantation (2 papers)Acta Haematologica (2 papers)Radiation Research (1 paper)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Jay Marshall Feingold
42 papers receiving 1.7k citations
Jay Marshall Feingold's Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 773
- Pathology and Forensic Medicine 471
- Cancer Research 228
- Genetics 146
- Pulmonary and Respiratory Medicine 427
Countries citing papers authored by Jay Marshall Feingold
This map shows the geographic impact of Jay Marshall Feingold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Marshall Feingold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Marshall Feingold more than expected).
Fields of papers citing papers by Jay Marshall Feingold
This network shows the impact of papers produced by Jay Marshall Feingold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Marshall Feingold. The network helps show where Jay Marshall Feingold may publish in the future.
Co-authors
The 25 scholars most cited alongside Jay Marshall Feingold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial Hit paper breakdown → | 2021 | 353 |
| 2 | 2009 | 219 | |
| 3 | 2020 | 146 | |
| 4 | 2008 | 142 | |
| 5 | 2019 | 87 | |
| 6 | 2009 | 75 | |
| 7 | 2021 | 73 | |
| 8 | 1977 | 60 | |
| 9 | 2003 | 59 | |
| 10 | 2009 | 51 | |
| 11 | 1999 | 48 | |
| 12 | 2020 | 47 | |
| 13 | 1999 | 46 | |
| 14 | 1985 | 39 | |
| 15 | 2020 | 34 | |
| 16 | 2000 | 32 | |
| 17 | 2010 | 27 | |
| 18 | 2001 | 20 | |
| 19 | 1988 | 19 | |
| 20 | 1997 | 18 |
About Jay Marshall Feingold
Jay Marshall Feingold is a scholar working on Oncology, Pathology and Forensic Medicine, Molecular Biology, Genetics and Internal Medicine, having authored 44 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), CAR-T cell therapy research (6 papers), HER2/EGFR in Cancer Research (6 papers), Synthesis and pharmacology of benzodiazepine derivatives (5 papers), Bacterial Genetics and Biotechnology (4 papers), DNA Repair Mechanisms (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Renal cell carcinoma treatment (4 papers). The work is most often cited by research in Oncology (773 citations), Pathology and Forensic Medicine (471 citations), Cancer Research (228 citations), Genetics (146 citations) and Pulmonary and Respiratory Medicine (427 citations). Jay Marshall Feingold has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Anna Berkenblit, Andrew Louis Strahs, Karin Havenith, Mehdi Hamadani, Paolo Fabrizio Caimi, John A. Radford, David Ungar, Melhem Solh, Janice P. Dutcher and Gary R. Hudes. Their work appears in journals such as Blood, Hematological Oncology, Bone Marrow Transplantation, Acta Haematologica and Radiation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.